Related Experiment Video

Updated: May 26, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
06:57

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

Regional differences in the evolution of lung disease in children with cystic fibrosis

Zhanhai Li1, Don B Sanders, Michael J Rock

  • 1Department of Pediatrics, University of Wisconsin-Madison, Madison, Wisconsin 53792-9988, USA.

Pediatric Pulmonology
|December 14, 2011
PubMed

Insights

Pediatric cystic fibrosis (CF) patients show more severe lung disease in upper lung lobes, particularly the right side, linked to specific bacterial infections. This progression begins in early childhood, offering insights into targeted therapies.

Area of Science:

  • Pediatric Pulmonology
  • Cystic Fibrosis Research
  • Medical Imaging Analysis

Background:

  • Lung disease progression is a critical concern in pediatric cystic fibrosis (CF).
  • Understanding regional differences in CF lung disease evolution is crucial for effective management.
  • Early childhood onset of regional disparities in CF lung disease remains unclear.

Purpose of the Study:

  • To investigate regional differences in lung disease progression in pediatric cystic fibrosis patients.
  • To determine if these regional differences emerge in early childhood.
  • To correlate lung disease severity with specific bacterial infections and anatomical locations.

Main Methods:

  • Evaluated 132 pediatric CF patients from the Wisconsin Neonatal Screening Project (1985-2010).
  • Utilized chest X-rays scored with the Wisconsin system, dividing lungs into quadrants, focusing on bronchiectasis (BX) and opacities.
  • Performed confirmatory analysis on CT scans from 81 patients using the Brody scoring system.

Main Results:

  • Chest X-rays revealed significantly higher BX and nodular/branching opacities in upper lung quadrants compared to lower quadrants (P<0.001).
  • CT scans confirmed more severe BX in upper quadrants (P=0.02).
  • Patients with mucoid Pseudomonas aeruginosa (PA) exhibited higher BX scores (P=0.001); upper right quadrants showed more BX than upper left (P<0.001).

Conclusions:

  • Pediatric CF patients develop more severe lung disease in upper lobes, especially the right side, associated with mucoid PA infections.
  • Regional lung disease progression in CF begins early in childhood.
  • Findings suggest potential therapeutic insights, possibly related to aspiration episodes.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome07:38

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome

Published on: August 3, 2021

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...